Thursday, January 28, 2021 2:21:31 PM
They call me Lazarous!
Recent LQDA News
- Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD • GlobeNewswire Inc. • 05/10/2024 12:00:00 PM
- Liquidia Corporation to Present at BofA Securities Health Care Conference 2024 • GlobeNewswire Inc. • 05/07/2024 12:30:00 PM
- Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024 • GlobeNewswire Inc. • 05/07/2024 12:00:00 PM
- Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/02/2024 01:00:10 PM
- Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder • GlobeNewswire Inc. • 04/01/2024 10:00:44 AM
- Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/13/2024 10:00:00 AM
- Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024 • GlobeNewswire Inc. • 03/06/2024 11:30:41 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 12:07:54 AM
- Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress • GlobeNewswire Inc. • 01/30/2024 11:30:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 12:01:42 PM
- Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder • GlobeNewswire Inc. • 01/25/2024 11:00:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 12:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 12:01:41 PM
- Liquidia Corporation Announces Updates to Operations Leadership • GlobeNewswire Inc. • 01/19/2024 11:30:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 10:04:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 10:03:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 10:02:54 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/16/2024 12:42:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:15:50 PM
- Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims • GlobeNewswire Inc. • 01/08/2024 01:22:54 PM
- Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD • GlobeNewswire Inc. • 01/05/2024 11:45:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 02:37:39 AM
- Liquidia Corporation Announces $100 Million in New Financings • GlobeNewswire Inc. • 01/04/2024 02:10:24 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/04/2024 05:15:19 AM
- Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/02/2024 11:45:31 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM